Godavari Biorefineries Ltd. (GBL) has achieved a significant milestone in the chemical industry by winning the esteemed ICC K.V. Mariwala Award for Effective Chemical Industry-Academia Partnership for the year 2024. This recognition comes in collaboration with the Institute of Chemical Technology Mumbai, highlighting the company's commitment to fostering strong industry-academia relationships.

Award Details and Recognition

The Indian Chemical Council (ICC) Awards Selection Committee carefully evaluated GBL's nomination and recommended the company for this prestigious honor. The ICC K.V. Mariwala Award is designed to recognize outstanding achievements and contributions in various facets of the chemical industry, with a particular focus on effective partnerships between industry and academia.

Collaboration with Institute of Chemical Technology Mumbai

Godavari Biorefineries' partnership with the Institute of Chemical Technology Mumbai played a crucial role in securing this award. This collaboration underscores the importance of synergy between industrial expertise and academic research in driving innovation within the chemical sector.

Award Presentation Ceremony

According to the company's disclosure to the stock exchanges, the award will be presented at the ICC Awards Presentation Function, scheduled for Friday, September 19, 2025. This event will honor various award winners for their exceptional contributions to the chemical industry for the year 2024.

Company's Response

Manoj Jain, Company Secretary & Compliance Officer of Godavari Biorefineries Limited, expressed the company's delight in receiving this recognition. In a statement to the stock exchanges, he mentioned, "We have great pleasure in informing you that the 'Awards Selection Committee' of ICC evaluated the nomination sent by Godavari Biorefineries Ltd. for ICC – K. V. MARIWALA AWARD FOR EFFECTIVE CHEMICAL INDUSTRY - ACADEMIA PARTNERSHIP and have recommended to confer the Award for the year 2024."

This award not only highlights Godavari Biorefineries' commitment to innovation but also emphasizes the growing importance of industry-academia collaborations in advancing the chemical sector. As the company prepares to receive this honor, it reinforces its position as a leader in fostering meaningful partnerships that drive progress in the chemical industry.

Godavari Biorefineries Limited , a leading integrated bio-refinery company, has reported a significant improvement in its financial performance for the first quarter. The company's strategic focus on ethanol production and specialty chemicals, coupled with operational efficiencies, has led to a notable turnaround in its EBITDA.

Financial Highlights

• Total income reached Rs. 534.00 crores, marking a 2% year-on-year increase.
• EBITDA showed a remarkable turnaround, reaching Rs. 6.50 crores compared to a negative Rs. 9.50 crores in the same quarter of the previous year.
• EBITDA margin improved to 1.2% from negative 1.8% in the previous year.
• Net loss narrowed to Rs. 16.00 crores from Rs. 26.10 crores year-on-year.
• Finance costs decreased to Rs. 15.30 crores from Rs. 19.60 crores, reflecting improved financial management.

Segment Performance

The ethanol segment emerged as a strong performer with a 51% revenue growth, while the chemicals segment saw a slight decline. The sugar and cogeneration segment experienced a more significant decrease in revenue.

Strategic Initiatives and Outlook

Godavari Biorefineries is actively expanding its ethanol capacity to capitalize on the growing demand. The company is constructing a 200 KLPD grain/maize distillery, which is expected to commence commercial production by the end of 2025. This expansion will add 60 million liters of annual ethanol capacity, enhancing the company's operational flexibility and supporting the government's ethanol blending initiative.

The management attributes the improved margins to several factors:

1. Restoration of the Ethanol Blending Program
2. Debottlenecking initiatives in specialty chemicals
3. Reduced finance costs

Looking ahead, Godavari Biorefineries has set an ambitious target of achieving 3X EBITDA growth by FY29 from FY25 levels. To support this growth, the company plans to invest approximately Rs. 325.00 crores in various growth initiatives.

Focus on Bio-based and Specialty Chemicals

The company is increasing its focus on bio-based and specialty chemicals, which now account for 65% of revenue in Q1, up from 54% in the same quarter of the previous year. This shift towards higher-margin products is expected to drive sustainable growth and strengthen overall profitability.

R&D Milestones

Godavari Biorefineries has made significant progress in its drug discovery efforts:

• European patent validation for a novel anti-cancer molecule in Spain, the UK, and multiple EU member states.
• Patent granted by China's National Intellectual Property Administration for another anti-cancer molecule.
• Successful completion of safety trials for both molecules without dose-limiting toxicity.

These developments in the pharmaceutical sector could potentially open new revenue streams for the company in the future.

As Godavari Biorefineries continues to navigate the evolving market landscape, its strategic focus on ethanol, bio-based chemicals, and R&D initiatives positions the company for potential growth and improved financial performance in the coming years.